Package/Label Display Panel, Part 1 of 2
NDC 0555-9034-58
6 Blister Card Dispensers, 28 Tablets Each
Balziva®
(norethidrone and
ethinyl estradiol tablets USP)
0.4 mg/0.035 mg
Usual Dosage: One tablet daily for 28 consecutive days per menstrual
cycle in the following order: 21 light peach tablets followed by 7 white
tablets as prescribed.
See enclosed package insert for full prescribing information.
Pharmacist: Each foil pouch contains one combination “Detailed
Patient Labeling / Brief Summary Insert,” which is to be provided to
the patient with each prescription.
Rx only
SHAPING
WOMEN’S HEALTH®
Package/Label Display Panel, Part 2 of 2
BALZIVA norethindrone and ethinyl estradiol kit |
|
|
|
Part 1 of 2 | NORETHINDRONE AND ETHINYL ESTRADIOL norethindrone and ethinyl estradiol tablet | |
|
|
|
|
|
|
Part 2 of 2 | INERT inert tablet | |
|
|
|
|
|
|
|
Revised: 12/2021 Teva Pharmaceuticals USA, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/balziva/page/7/